WuXi Biologics Shows Exceptional Growth: Bispecific Antibodies Key Player
WuXi Biologics achieved remarkable success in 2025 with a total of 945 integrated projects, setting a new record with 209 new projects, half of which came from U.S. clients. These.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
